RS62823B1 - Postupak za proizvodnju alfa-oblika vortioksetin hbr-a - Google Patents

Postupak za proizvodnju alfa-oblika vortioksetin hbr-a

Info

Publication number
RS62823B1
RS62823B1 RS20220047A RSP20220047A RS62823B1 RS 62823 B1 RS62823 B1 RS 62823B1 RS 20220047 A RS20220047 A RS 20220047A RS P20220047 A RSP20220047 A RS P20220047A RS 62823 B1 RS62823 B1 RS 62823B1
Authority
RS
Serbia
Prior art keywords
alpha
manufacture
vortioxetine hbr
vortioxetine
hbr
Prior art date
Application number
RS20220047A
Other languages
English (en)
Inventor
Hans Petersen
Original Assignee
H Lundbeck As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=62111030&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=RS62823(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by H Lundbeck As filed Critical H Lundbeck As
Publication of RS62823B1 publication Critical patent/RS62823B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/096Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms separated by carbocyclic rings or by carbon chains interrupted by carbocyclic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cephalosporin Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
RS20220047A 2017-04-25 2018-04-20 Postupak za proizvodnju alfa-oblika vortioksetin hbr-a RS62823B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DKPA201700264 2017-04-25
EP18721975.3A EP3615518B1 (en) 2017-04-25 2018-04-20 Process for the manufacture of vortioxetine hbr alpha-form
PCT/EP2018/060192 WO2018197360A1 (en) 2017-04-25 2018-04-20 Process for the manufacture of vortioxetine hbr alpha-form

Publications (1)

Publication Number Publication Date
RS62823B1 true RS62823B1 (sr) 2022-02-28

Family

ID=62111030

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20220047A RS62823B1 (sr) 2017-04-25 2018-04-20 Postupak za proizvodnju alfa-oblika vortioksetin hbr-a

Country Status (26)

Country Link
US (1) US11124491B2 (sr)
EP (1) EP3615518B1 (sr)
JP (1) JP7121751B2 (sr)
KR (1) KR102551433B1 (sr)
CN (1) CN110520415A (sr)
AU (1) AU2018258947C1 (sr)
BR (1) BR112018076411A2 (sr)
CA (1) CA3059515A1 (sr)
CL (1) CL2019003024A1 (sr)
CO (1) CO2019011592A2 (sr)
CY (1) CY1124974T1 (sr)
DK (1) DK3615518T3 (sr)
ES (1) ES2905962T3 (sr)
HR (1) HRP20220108T1 (sr)
HU (1) HUE057993T2 (sr)
IL (1) IL270052B2 (sr)
LT (1) LT3615518T (sr)
MA (1) MA49056A (sr)
MX (1) MX2019012765A (sr)
PL (1) PL3615518T3 (sr)
PT (1) PT3615518T (sr)
RS (1) RS62823B1 (sr)
SG (1) SG11201909678PA (sr)
SI (1) SI3615518T1 (sr)
WO (1) WO2018197360A1 (sr)
ZA (1) ZA201906829B (sr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210087155A1 (en) * 2018-02-06 2021-03-25 Piramal Enterprises Limited An improved process for the preparation of vortioxetine and salts thereof
CN112125868B (zh) * 2020-09-25 2021-08-03 中山万远新药研发有限公司 一种氢溴酸伏硫西汀晶型及其制备方法、组合物与用途

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
UA81749C2 (uk) 2001-10-04 2008-02-11 Х. Луннбек А/С Фенілпіперазинові похідні як інгібітори зворотного захоплення серотоніну
CN101472906B (zh) 2006-06-16 2012-04-25 H.隆德贝克有限公司 作为用于治疗认知损伤的、具有结合的对血清素再吸收、5-ht3和5-ht1a活性的化合物的1-[2-(2,4-二甲基苯基硫烷基)-苯基]哌嗪
TW200848411A (en) 2007-03-20 2008-12-16 Lundbeck & Co As H Novel therapeutic uses of 1-[2-(2, 4-dimethylphenylsulfanyl)phenyl]-piperazine
TW201033181A (en) 2009-02-17 2010-09-16 Lundbeck & Co As H Purification of 1-[2-(2,4-dimethylphenylsulfanyl)phenyl]piperazine
CN104797566B (zh) 2012-09-19 2017-07-07 桑多斯股份公司 沃替西汀氢溴酸盐的新结晶形式
US9822086B2 (en) * 2014-01-31 2017-11-21 Egis Gyogyszergyar Zrt. Process for the preparation of vortioxetine salts
US9687484B2 (en) 2014-07-18 2017-06-27 Dipharma Francis S.R.L. Crystalline forms of an antidepressant compound
CN105367515B (zh) * 2015-05-08 2017-10-27 北京北陆药业股份有限公司 一种氢溴酸沃替西汀α晶型的制备方法
CN104910099B (zh) 2015-05-22 2017-03-08 扬子江药业集团有限公司 一种氢溴酸沃替西汀晶体的制备方法
CN106316986B (zh) 2015-07-03 2019-02-05 成都弘达药业有限公司 一种1-[2-(2,4-二甲基苯基硫烷基)苯基]哌嗪氢溴酸盐α型晶体的制备方法

Also Published As

Publication number Publication date
IL270052B2 (en) 2023-12-01
PT3615518T (pt) 2022-02-14
HUE057993T2 (hu) 2022-06-28
CY1124974T1 (el) 2023-01-05
ES2905962T3 (es) 2022-04-12
MA49056A (fr) 2020-03-04
RU2019133770A3 (sr) 2021-08-27
US11124491B2 (en) 2021-09-21
JP7121751B2 (ja) 2022-08-18
EP3615518A1 (en) 2020-03-04
IL270052B1 (en) 2023-08-01
CO2019011592A2 (es) 2019-10-31
ZA201906829B (en) 2022-03-30
CA3059515A1 (en) 2018-11-01
EP3615518B1 (en) 2021-12-15
KR20190141155A (ko) 2019-12-23
MX2019012765A (es) 2019-12-05
BR112018076411A2 (pt) 2019-04-09
AU2018258947A1 (en) 2019-10-31
CL2019003024A1 (es) 2020-02-21
AU2018258947B2 (en) 2021-02-25
IL270052A (sr) 2019-12-31
CN110520415A (zh) 2019-11-29
WO2018197360A1 (en) 2018-11-01
PL3615518T3 (pl) 2022-03-07
HRP20220108T1 (hr) 2022-04-15
SG11201909678PA (en) 2019-11-28
US20200165217A1 (en) 2020-05-28
JP2020517674A (ja) 2020-06-18
AU2018258947C1 (en) 2021-08-26
KR102551433B1 (ko) 2023-07-04
RU2019133770A (ru) 2021-05-25
DK3615518T3 (da) 2022-02-07
LT3615518T (lt) 2022-03-10
SI3615518T1 (sl) 2022-02-28

Similar Documents

Publication Publication Date Title
SI3433285T1 (sl) Izboljšan postopek za pripravo sugamadeksa
ZA201706795B (en) Process for the preparation of dicycloplatin
SI3630738T1 (sl) Postopek za ustvarjanje ozanimoda
IL264074B (en) Industrial process for the preparation of caprazine
ZA201902125B (en) Process for the production of 2-alkylalkanol
IL266589B1 (en) A process for the preparation of omclidinium bromide
ZA201601869B (en) Improved process for the preparation of apremilast
HRP20190403T1 (hr) Postupak izrade lakozamida
EP3233814A4 (en) Novel process for the preparation of ranolazine
IL268835B (en) A process for the preparation of 2-cyanoimidazole compounds
PT3286373T (pt) Métodos para a produção de nanocelulose com alto teor de sólidos
ZA201906829B (en) Process for the manufacture of vortioxetine hbr alpha-form
IL275480A (en) A process for the preparation of pyrimidinyl-4-aminopyrazole compounds
PL3519382T3 (pl) Ulepszony sposób wytwarzania lakozamidu
ZA201808387B (en) Improved process for the preparation of carbamates
HUP1500502A2 (en) Process for the purification of cyclosporin-a
IL262889B (en) Process for the manufacture of 6-alkynyl-pyridine derivatives
IL267305A (en) Process for the manufacture of diazepine derivatives
PL3489218T3 (pl) Sposób wytwarzania fenyloaminohydroksyantrachinonów
GB201717809D0 (en) Process for the production of cobimetinib
EP3344249A4 (en) Processes for the preparation of ivacaftor
GB201607927D0 (en) Composition & process